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About This Report 
About NLCAHR  
The Newfoundland and Labrador Centre for Applied Health Research, established in 1999, 
contributes to the effectiveness of health and community services in Newfoundland and 
Labrador and to the physical, social, and psychological wellbeing of its population. NLCAHR 
accomplishes this mandate by building capacity in applied health research, supporting high-
quality research, and fostering the effective use of research evidence by decision makers 
and policy makers in the provincial healthcare system. 
 
Rapid Evidence Reports 
NLCAHR designed Rapid Evidence Reports to provide support for evidence-based decision 
making in the Newfoundland and Labrador healthcare system on an expedited basis as 
compared to the lengthier ‘Evidence in Context’ reports issued through the Contextualized 
Health Research Synthesis Program.  Through these expedited reports, NLCAHR provides a 
succinct review of recent research evidence on a high-priority research topic selected by 
decision makers in the province. 
 
Rapid Evidence Reports include: 
 a clear statement of the issue and the background to the issue/problem; 
 a description of the scope and nature of the pertinent English-language scientific 
literature from the past five years; 
 a summary of the principal features of the available evidence – points of consensus, 
points of disagreement, areas of uncertainty or silence on some or all of the 
following issues: effectiveness of interventions, potential benefits and harms, risks, 
costs, and cost-effectiveness; and 
 a brief analysis of the types of issues that might affect the applicability of the 
evidence to the local context. 
 
It is important to note that, unlike an ‘Evidence in Context’ report, a Rapid Evidence Report is 
not a comprehensive and systematic synthesis of the literature on the topic. The rapid 
report provides neither critical appraisal of included articles nor a full analysis of the 
contextual issues involved in applying evidence to the Newfoundland and Labrador 
healthcare setting.  Rather, a Rapid Evidence Report provides decision makers with a 
summary of the scope and nature of the recent scientific literature on the topic in question, 
an initial assessment of the strengths and gaps in this literature, and a review of the key 
points of agreement and disagreement among researchers.   
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Researchers and Consultants 
For this report, researchers from the Newfoundland and Labrador Centre for Applied Health 
Research included: Robert Kean, Research Officer, Contextualized Health Research Synthesis 
Program (CHRSP), Dr. Stephen Bornstein, Director of NLCAHR, and Stephanie O’Brien, 
Research Assistant.  Our team benefitted from the advice and expertise of Dr. Robert Reid, 
Deputy Chief of the Division of Prevention and Rehabilitation at the University of Ottawa 
Heart Institute and Full Professor in the Faculty of Medicine at the University of Ottawa.  Dr. 
Reid’s credentials are included in the Appendix to this report on page 17. 
 
Background 
 
Heart failure is a condition in which the heart is unable to pump out enough blood to meet 
the metabolic needs of the body.  It can be caused by structural defects, functional 
abnormalities, or a sudden overload beyond its capacity. Chronic heart failure (CHF) is more 
common than acute heart failure, which results from sudden insult to cardiac function.  CHF 
is diagnosed in 1–2% of the general population in industrialized countries, and spending on 
the disease represents 1–2% of their total health-care expenditures.  Mortality and 
hospitalization rates associated with CHF are among the highest of any medical condition 
(1). 
 
On the suggestion of the Central Regional Health Authority,1 our stakeholder partners have 
asked us to identify any and all ambulatory care programs and interventions that have been 
shown to reduce hospital admissions and mortality among patients with CHF.  In requesting 
this review, our partners have noted that: 
 
There is a significant demand for acute care beds…  At times, surgeries have to be 
cancelled and patients are on stretchers in the ER for significant periods of time.  
Patients with chronic conditions are sometimes admitted to hospital as the required 
outpatient programs/services have not been developed to provide the required 
level of care for these patients. 
 
This review defines “ambulatory care” as any sort of service or program provided outside an 
acute hospital inpatient unit.  This includes professional services delivered in outpatient 
clinics, in patients’ homes, or via some form of telehealth technology.  At the stakeholders’ 
request, we have not included research articles that focus exclusively on models of patient 
self-management; however, some of the articles reviewed here evaluate packages of 
interventions that include a self-management component. We have also excluded from the 
analysis articles that focus exclusively on either prescription medications or surgical 
                                                          
1
 Between April 2012 and March 2013, the Central Health Region reported 432 cases of heart failure. 
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interventions.  Our review is further limited to research articles that measure the effect of 
programs on both hospitalization and mortality rates.  
 
 
Our research question is as follows:  
  
 
“What ambulatory care services and/or programs have proved effective in 
reducing hospitalization and mortality among patients with chronic heart 
failure?” 
 
 
Scope and Nature of the Scientific 
Literature 
 
For this review, we sought systematic reviews and primary studies published in English since 
October 2008.2  We excluded from consideration any primary study that had already been 
included in one of the systematic reviews we identified.  We also excluded unpublished or 
grey literature.  In total, our review includes twelve systematic reviews and 29 primary 
studies.  Of the 29 primary studies:  
 20 were randomized controlled trials (RCTs),  
 3 used non-randomized comparative designs, and  
 6 studied a single group or cohort with no control or comparison group. 
 
We have categorized this literature under three main headings: clinic-based CHF 
management, home-based CHF management, and telemedicine.  We define and describe 
each of these below, but we would note here that there is some overlap between these 
categories.  For instance, a number of the interventions discussed in the section on 
telemedicine involve both remote monitoring and forms of telephone support that may 
arguably qualify as home-based interventions according to our definition. 
 
One final note about the articles under review concerns their geographical setting.  The 
available research literature comprises studies conducted in many parts of the world, 
including Canada, the United States, South America, Western Europe, Australia/New 
Zealand, Israel, and Japan.  This mix of countries and regions represents a diverse array of 
healthcare systems many of which are very different in various ways from this province and, 
                                                          
2
 We assume that evidence from earlier studies will have been captured by the systematic review 
literature included in this report. 
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for that reason, the findings generated by these papers may not always be directly 
generalizable to the local context.  
 
 
Clinic-Based CHF Management 
 
We define clinic-based CHF management as any package of services delivered by healthcare 
professionals in an outpatient clinic that specializes in CHF care.  There is no consensus in 
the literature we retrieved concerning the benefits of clinic-based services.  We identified 
three RCTs (2-4) on clinic-based services and two systematic reviews of RCTs, including one 
Cochrane review (5).  The intervention groups in these articles were compared with patients 
receiving general practitioner (GP)-led CHF management, cardiologist-led CHF management, 
or some combination of both.  Only one of these five articles – a systematic review of 
studies of supervised exercise therapy (6) – found that clinic-based care had a significantly 
greater effect on hospitalizations than did the care received by control groups (Risk ratio = 
0.90, 95% CI 0.831—0.973),3 and none found an effect on mortality.  This finding of no effect 
was consistent at study follow-up periods ranging from six months to several years and in 
patient populations with varying levels of CHF severity.4  Furthermore, the no-effect finding 
was consistent no matter what form of ‘usual care’ was chosen as a control – GP-led 
management, cardiologist-led management, or some combination of the two.   According to 
the 2012 Cochrane review by Takeda et al., “There is little currently available evidence to 
support interventions whose major component is follow-up in a heart failure clinic” (5, p. 
17). 
 
Schou et al. speculate that the neutral effect observed in their study might be attributable 
to the high quality of the “usual” care received by their control group (3).  As it happens, all 
three of the aforementioned RCTs – including the one by Schou et al. – were conducted in 
Denmark, which boasts a publicly-funded primary care system that provides >90% of all 
Danes with access to a personal family physician.  Furthermore, elderly Danes are eligible to 
receive home visits by a geriatric nurse as part of their routine care, and all Danes can avail 
themselves of a national prescription drug plan in which annual medication-related 
expenses incurred by outpatients are capped at 500 Euros (3).  Takeda et al. do not discuss 
the quality of care received by control groups in the RCTs included in their meta-analysis, 
                                                          
3
 It should be noted that in each case there is a range of values – called a confidence interval (CI) – 
within which the true value of the estimated reduction in hospitalization is expected to lie.  So, while 
the point estimate given for the reduction in hospitalizations is 10%, it is also noted that 95 times out 
of 100 this number will actually fall anywhere between 3 and 17% 
 
4
 Articles included in this review assessed CHF severity using the New York Heart Association (NYHA) 
performance scale.  The NYHA scale classifies heart failure as mild (stage I–II), moderate (stage III) or 
severe (stage IV) based on symptomatic markers (9). 
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but it may be worth noting that these studies were conducted in Sweden, the Netherlands, 
New Zealand, and the U.K. 
 
However, this finding of no effect for clinic-based care was not unanimous in all the studies 
in our review.  We identified a number of studies on this subject that used either a non-
randomized comparative design or a single-group before-and-after design, and these tended 
to support the effectiveness of specialized CHF clinics.  Jain et al. retrospectively evaluated 
the effectiveness of a hospital-based multidisciplinary clinic in Baltimore and found that 
patients treated at the clinic had lower readmission rates than those treated by a general 
practitioner or cardiologist (7).  There was no difference in mortality between the two 
groups.  Likewise, Feldman et al. studied a single cohort of CHF outpatients in Québec and 
observed a significant decrease in hospitalizations among those treated at participating CHF 
clinics (8). 
 
 
Telemedicine 
 
We discovered an extensive literature on telemedical interventions for the management of 
CHF, comprising nine systematic reviews and ten primary studies published in the past five 
years .  The most recent of these articles is a 2013 health technology assessment prepared 
by Pandor et al. under the auspices of the National Institute for Health Research (NIHR) in 
the U.K.  Because this was the most comprehensive and up-to-date source we could find on 
telemedical interventions – and because the NIHR is widely recognized for the quality of the 
health research information it produces – we rely heavily on it in the analysis that follows. 
 
We also make use of these authors’ definitions of telemedical interventions.  Pandor et al. 
group the various telemedical approaches to CHF management into two main categories: 
 
 telemonitoring, in which physiological data are electronically transmitted to a health 
care team; and 
 structured telephone support (STS), in which telephone calls are used to deliver self-
care support and/or management. 
 
Pandor et al. break STS down further into human-to-human and machine-to-human forms 
of telephone support.  In the human-to-human variants of STS, calls are typically made by 
specialist nurses and include advice on self-care and medication.  In the machine-to-human 
variants, patients respond to automated questions about their symptoms by responding on 
their telephone keypads.  Telemonitoring interventions generally require patients to take 
measurements of vital parameters such as weight, blood pressure, and heart rate; these 
data are then transmitted to health care providers by telephone or broadband technology.  
In some systems, readings outside of prespecified limits generate automated warnings.  Just 
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as with STS interventions, Pandor et al. divide telemonitoring interventions into two main 
categories:  
 
 those in which medical staff review transmitted data and, if necessary, provide 
support only during office hours; and  
 those which require the constant – i.e., 24 hours a day, 7 days a week – presence of 
medical personnel (9). 
 
After performing a sensitivity analysis that excluded a study whose control group was 
treated differently than the control groups from the others, Pandor et al. found that, for 
CHF patients recently discharged from hospital, both telemonitoring with medical support 
during office hours and  human-to-human STS were associated with significant reductions in 
all-cause mortality as compared to controls (Hazard ratio = 0.62, 95% CI 0.42—0.89 and 
0.75, 95% CI 0.59 to 0.96, respectively).5  Furthermore, telemonitoring with support during 
office hours was associated with a signficant reduction in all-cause hospitalization (Hazard 
ratio = 0.67, 95% CI 0.42—0.97), and human-to-human STS was associated with a significant 
reduction in CHF-related hospitalizations (Hazard ratio = 0.77, 95% CI 0.62—0.96) (9), p. 
xiv).6  By contrast, these researchers did not observe any beneficial effects associated with 
machine-to-human forms of STS.  These findings are broadly consistent with the other 
systematic reviews we found, including Cochrane reviews by Takeda et al. and Inglis et al. 
and a health technology assessment published by the Canadian Agency for Drugs and 
Technology in Health (1,5,10). 
 
We also identified five RCTs that were published after Pandor et al. concluded their 
literature search; two of these (11,12) corroborated the findings of the reviews and three 
did not.  However, two of these studies lacked the statistical power  to detect differences in 
mortality/hospitalizations (13,14), and the third was focused exclusively on electronic 
weight monitoring (15).   
  
 
Home-Based CHF Management 
 
We define home-based CHF management as any package of interventions delivered by 
health care professionals in patients’ homes.  While differences exist among the various 
models of home-based management, three elements are common to most. First, home 
visits are conducted by one or more health professionals, most often a nurse with 
                                                          
5
 Because they found only one study on 24-7 telemonitoring, and because they judged this study to 
be of poor quality, Pandor et al. declined to draw any definitive conclusions about this intervention. 
 
6
 Pandor et al. also conducted a meta-analysis of studies involving patients with stable heart failure, 
but the results were inconclusive (9), pp. 31-4). 
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specialized training in CHF or a physician. Second, home visits typically include some form of 
assessment, education and counselling, and monitoring of vital signs.  Third, results from 
home visits are often reported to a specialist physician or cardiologist for possible follow-up 
and subsequent adjustment of the patient’s care plan. The frequency of home visits can vary 
from daily to once a month and is often dependent on the nature and severity of the 
patient’s condition.  Oftentimes, home visits are supplemented by STS.  
 
We identified ten primary studies on home-based CHF services: nine RCTs and one time-
series comparison study. Three of the RCTs compared very specific home-based 
interventions – echocardiography (16), pharmacist-directed medication reviews (17), and 
monitoring of N-terminal pro-brain natriuretic peptide (NT-proBNP) levels (18) – with ‘usual’ 
home-based care. Only NT-proBNP-guided care was associated with a significant reduction 
in mortality and re-hospitalization rates (18).  Almost all of the patients selected for this 
study had NYHA grade III or IV heart failure.  Three RCTs compared more general home-
based CHF management programs with routine outpatient management by a family 
physician or cardiologist.  Two of these found that home-based interventions for patients 
with mild CHF (NYHA grade I – II) effectively reduced CHF-related hospitalizations without 
increasing the risk of mortality (Hazard ratio = 0.52, 95% CI 0.27—0.96 and 0.70, 95% CI 
0.55—0.99) (19,20).  The third study was unable to draw strong conclusions on the 
effectiveness of home-based interventions because of the small number of patients 
recruited to the study (21).   
 
Three other RCTs compared home-based management programs with either hospital 
inpatient care or specialized, outpatient, clinic-based care.  None of these studies observed 
significant differences between intervention and control groups in terms of the rate of 
hospitalization or mortality, indicating that home-based interventions are at least as safe 
and effective as the institutionally-based alternatives.  Both Mendoza et al. and Tibaldi et al.  
compared “Hospital at home” (HaH) interventions for elderly CHF patients with inpatient 
hospital care; the former concluded that HaH “avoids traditional hospital admission for 
patients with decompensated chronic HF with no significant differences in clinical and 
functional outcomes at 1 year of follow-up” (22, p. 1212), while the latter observed a longer 
time to first admission in the intervention group (23).7  Moreover, Stewart et al. found that 
home-based interventions for patients with NYHA II and III grade symptoms were 
“associated with a significant reduction in the duration of recurrent hospitalization and 
more prolonged survival free from hospitalization” (24, p. 1247).   
 
The studies that found evidence in support of home-based CHF management identified a 
couple of factors that may help to account for the success of these interventions.  Visits to 
                                                          
7
 It should be noted that the patients in the study by Tibaldi et al. had considerably more severe CHF 
symptoms than the patients in the study by Mendoza et al.  The study population in the former study 
were 65% NYHA grade III and 35% grade IV; by contrast, the study population in the former were 59% 
grade II and 41% grade III. 
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patients and their significant others in their home environments may facilitate more 
comprehensive assessments of patients’ overall clinical and psychosocial status and, 
therefore, more individually-tailored care.  This more intensive, tailored support may in turn 
enhance patient engagement and compliance with recommended treatments. 
 
In summary, the articles we reviewed appear to suggest that ambulatory CHF care services 
delivered closer to home – whether in form of actual visits to patients’ homes or of 
telemedical intervention – appear to be effective in reducing hospitalizations without 
increasing the risk of mortality.  By contrast, there is no consensus in the literature we 
reviewed concerning the benefits of care delivered in specialized outpatient clinics.  We 
would further remind the reader that our report focuses solely on the effects of CHF 
interventions on hospital admissions and morality rates; these interventions may well have 
important effects on other patient-related outcomes (e.g., functional capacity, activities of 
daily living, and quality of life). 
 
 
Potentially Relevant Contextual Issues 
 
Throughout the course of this project, we have tried to identify contextual factors unique to 
Newfoundland and Labrador – and the Central Regional Health Authority in particular – that 
may influence the relevance and applicability of the research-based evidence. This section 
of the report addresses those factors in brief. 
 
Geography and Service Landscape 
Perhaps the most salient contextual issue confronting Newfoundland and Labrador is the 
dispersal of its healthcare facilities over a vast terrain.  The Central Health Region, for 
instance, extends from Charlottetown in the east to the Baie Verte Peninsula in the west, 
and from Fogo Island in the north to Harbour Breton in the south. Urban areas such as 
Gander, Grand Falls-Windsor, and Lewisporte are readily accessible, but a number of the 
more remote communities within the Central Region are an hour’s drive away from the 
nearest of the health authority’s approximately 30 continuing care nurses.  Poor weather – 
not infrequent in Central Newfoundland – can lengthen these driving times even further.  
Moreover, a handful of communities can be reached only by ferry.  The geography of the 
Central Health Region would likely pose significant challenges to implementation of a home 
visitation program for CHF patients and the same is true for much of the rest of the province 
as well.  However, it may be worth noting that Central Health’s continuing care nurses 
already make home visits on a case-by-case basis to a select number of high-risk patients.  
Should the health authority wish to experiment with home visits for CHF patients, it would 
have some in-house experience to draw upon. 
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Financial, Administrative, and Human Resources 
The telemedical and home-based interventions in the studies under review were delivered 
by nurses or other healthcare professionals with specialized training in CHF.  To our 
knowledge, at present, continuing-care nurses in the Central Region have not acquired this 
specialized training.  Before proceeding with any new programming, a health authority 
would be well-advised to take stock of the training needs of existing personnel to make sure 
they have the skills to deliver these interventions effectively. 
 
Organizational Strengths 
Newfoundland and Labrador has developed a comprehensive telehealth infrastructure that 
includes communication channels, technical support services, and an established network of 
remote telehealth sites. In 2006, the province launched HealthLine, a toll-free telephone 
service that provides callers with health advice and information.  Callers to HealthLine speak 
to a registered nurse who follows computerized standardized guidelines in order to 
recommend the most appropriate action.  Therefore, there is already some existing capacity 
on which Central Health can draw should it wish to deliver targeted STS services for CHF 
patients in the region.  There may also be some potential for using the province’s telehealth 
infrastructure to provide innovating training opportunities for health care providers 
interested in upgrading their skills.   
 
 
Summary of Key Points 
 
 There is a lack of consensus in the literature concerning the benefits of services 
delivered in specialized clinics. 
 
 Both (a) telemonitoring with medical support during office hours and (b) human-to-
human STS appear to be effective in reducing hospitalizations without increasing the 
risk of mortality. 
 
 Home-based CHF management interventions (23) appear to be at least as safe and 
effective as similar services delivered in hospitals or specialist clinics, and may have 
important advantages over routine outpatient management by a cardiologist and/or 
general practitioner. 
 
 The province’s geography – and the geography of the Central Health Region in 
particular – would likely pose significant challenges to implementation of an 
extensive home visitation program for CHF patients. 
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 Health authorities would be well advised to take stock of the training needs of 
existing personnel to make sure they have the capacity to deliver evidence-based 
CHF management interventions effectively. 
 
 There is already existing capacity for health authorities to draw upon should they 
wish to deliver targeted STS services for CHF patients living in the community. 
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